Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies ...

Two patients with monoclonal anti-PF4 antibodies, thrombosis, and chronic thrombocytopenia also had first-trimester pregnancy losses, findings that suggest a possible link between these antibodies ...

The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases. In respiratory medicine, monoclonal antibodies have already transformed the ...

Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma-cell proliferative disorder that is present in approximately 5% of the general population over the age of 50 ...

In a patient with treatment-resistant ulcerative colitis, CD19 CAR T-cell therapy led to drug-free remission and mucosal healing, suggesting that B-cell targeting may offer a novel therapeutic pathway ...

Hereditary angioedema is a rare genetic disease characterized by severe and unpredictable swelling attacks. NTLA-2002 is an in vivo gene-editing therapy that is based on clustered regularly ...

A previously healthy 36-year-old woman presented with a 2-day history of severe chest pain and epigastric pain associated with nausea and vomiting. The patient reported that she had consumed uncooked ...

To the Editor: Harrison et al. (Feb. 8 issue) 1 found that resmetirom treatment reduced levels of free thyroxine (FT4) by approximately 16 to 19% in patients with nonalcoholic steatohepatitis (NASH).

Although discrimination both by clinicians and by patients and families is relatively common in the United States, the laws that can be used to address these two types of discrimination differ subs ...

To the Editor: The REGENCY trial reported by Furie et al. (April 17 issue) 1 showed that obinutuzumab added to standard therapy was more effective than standard therapy alone in achieving complete ...